|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment. |
| 公司地址
| 4400 Biscayne Boulevard, Miami, FL, USA, 33137 |
| 電話號碼
| +1 305 575-4100 |
| 傳真號碼
| +1 305 575-6016 |
| 公司網頁
| https://www.opko.com |
| 員工數量
| 2275 |
| Dr. Elias A. Zerhouni, M.D. |
President and Vice Chairman of the Board |
美元 900.00K |
26/02/2026 |
| Dr. Tony F. Cruz |
Chief Executive Officer of Transition Therapeutics |
-- |
14/03/2025 |
| Mr. Steven D. Rubin |
Director and Executive Vice President, Administration |
美元 810.00K |
26/02/2026 |
| Dr. Jane H. Hsiao, M.B.A.,PhD |
Vice Chairman of the Board and Chief Technical Officer |
美元 900.00K |
26/02/2026 |
| Dr. Gary J. Nabel, M.D.,PhD |
Chief Innovation Officer and Director |
-- |
26/02/2026 |
| Dr. Phillip Frost, M.D. |
Chairman of the Board and Chief Executive Officer |
美元 960.00K |
26/02/2026 |
| Dr. Charles W Bishop, PhD |
Chief Executive Officer, OPKO Renal |
-- |
14/03/2025 |
| Mr. Adam E. Logal |
Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer |
美元 700.00K |
14/03/2025 |
|
|
| Dr. Elias A. Zerhouni, M.D. |
President and Vice Chairman of the Board |
26/02/2026 |
| Mr. Richard C. Pfenninger, Jr |
Lead Independent Director |
14/03/2025 |
| Mr. John A. Paganelli |
Independent Director |
26/02/2026 |
| Dr. Richard M. Krasno, PhD |
Independent Director |
26/02/2026 |
| Dr. Alice Lin-Tsing Yu, M.D.,PhD |
Independent Director |
26/02/2026 |
| Mr. Richard C Pfenniger, Jr |
Director |
26/02/2026 |
| Mr. Steven D. Rubin |
Director and Executive Vice President, Administration |
26/02/2026 |
| Dr. Jane H. Hsiao, M.B.A.,PhD |
Vice Chairman of the Board and Chief Technical Officer |
26/02/2026 |
| Dr. Prem A. Lachman, M.D. |
Independent Director |
26/02/2026 |
| Dr. Gary J. Nabel, M.D.,PhD |
Chief Innovation Officer and Director |
26/02/2026 |
| Dr. Phillip Frost, M.D. |
Chairman of the Board and Chief Executive Officer |
26/02/2026 |
| Dr. Roger J. Medel,M.D. |
Independent Director |
26/02/2026 |
|
|
|
|
